Tango Therapeutics, Inc.TNGXNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 37 | 25 | 37 |
| Gross Profit | 37 | 25 | 37 |
| Operating Income | -58 | -111 | -114 |
| Net Income | -58 | -108 | -102 |
| EBITDA | -57 | -109 | -112 |
| EPS Diluted | -0.94 | -1.23 | -1.08 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 143 | 60 | 66 |
| Total Current Assets | 492 | 375 | 347 |
| Total Assets | 500 | 436 | 403 |
| Total Current Liabilities | 41 | 56 | 46 |
| Total Liabilities | 155 | 187 | 149 |
| Total Equity | 345 | 249 | 253 |
| Total Debt | 2 | 41 | 39 |
| Net Debt | -141 | -19 | -27 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -60 | -109 | -118 |
| Capital Expenditure | -2 | -8 | -2 |
| Free Cash Flow | -61 | -117 | -120 |
| Stock-Based Comp | 8 | 14 | 19 |
| Net Change in Cash | 114 | -81 | 6 |